BeStock  
Markets › Compare › AVTX vs NGNE

AVTX vs NGNE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AVTX · Avalo Therapeutics$6.76 ▲ 0.15%
NGNE · Neurogene$22.15 ▼ 3.40%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

2675123172220Nov 24, '25May 26, '26Nov 20, '26
  • AVTX -62.4%
  • NGNE +8.4%

Head to head

MetricAVTXNGNE
Price$6.76$22.15
Change today▲ 0.15%▼ 3.40%
Market cap$390.88M$458.53M
Return, 3 months-64.9%-44.1%
Return, year to date-62.8%+7.5%
Return, 1 year-62.1%+10.4%
P/E (TTM)––
P/B0.91.3
P/E percentile vs own 5y6th45th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)+38.1%-38.5%
Gross margin––
Operating margin-161,962.7%–
Net margin-150,259.3%–
Return on equity-33.6%-38.4%
Analyst target vs. price+284.6%+309.3%
Analyst buy share71%100%
RSI (14)3335
30-day volatility167.0%88.8%
Max drawdown, 1 year-71.0%-49.7%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NGNE is the largest of the group by market value.
  • NGNE has returned the most over the past year.
  • NGNE has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top